Matches in DBpedia 2015-10 for { ?s ?p "APG101 is a soluble CD95-Fc fusion protein which is in development for the treatment of Glioblastoma multiforme (GBM) and myelodysplastic syndromes (MDS). APG101 blocks the CD95–ligand (CD95L) from binding to the CD95-receptor (CD95). A randomized,double-blind, placebo-controlled phase I study to examine the safety and tolerability of APG101 has shown that it is well tolerated."@en }
Showing triples 1 to 1 of
1
with 100 triples per page.
- APG101 comment "APG101 is a soluble CD95-Fc fusion protein which is in development for the treatment of Glioblastoma multiforme (GBM) and myelodysplastic syndromes (MDS). APG101 blocks the CD95–ligand (CD95L) from binding to the CD95-receptor (CD95). A randomized,double-blind, placebo-controlled phase I study to examine the safety and tolerability of APG101 has shown that it is well tolerated.".